Brief: Maxcyte Proposes Cancellation Of AIM Listing, Continues Nasdaq Listing
15/04/2025 07:41
April 15 (Reuters) - MaxCyte Inc MXCT.O: MAXCYTE INC - PROPOSES CANCELLATION OF AIM LISTING, CONTINUES NASDAQ LISTING Source text: ID:nRSO9923Ea Further company coverage: MXCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview